{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T17:43:01Z","timestamp":1781890981802,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"crossref","award":["20244Y0152"],"award-info":[{"award-number":["20244Y0152"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Three-Year Initiative Plan for Strengthening Public Health System Construction in Shanghai","award":["GWVI-3"],"award-info":[{"award-number":["GWVI-3"]}]},{"name":"China Antimicrobial Surveillance Network","award":["Independent Medical Grants from Pfizer, 2020QD049"],"award-info":[{"award-number":["Independent Medical Grants from Pfizer, 2020QD049"]}]},{"name":"Shanghai Antimicrobial Surveillance Network","award":["3030231003"],"award-info":[{"award-number":["3030231003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s10096-025-05232-3","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T13:47:20Z","timestamp":1755006440000},"page":"2705-2715","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["In vitro activity of the novel \u03b2-lactamase inhibitor FL058 combined with meropenem against KPC- or NDM-producing enterobacterales and Pseudomonas aeruginosa"],"prefix":"10.1007","volume":"44","author":[{"given":"Feng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengkang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4493-0619","authenticated-orcid":false,"given":"Fupin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"issue":"10442","key":"5232_CR1","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1016\/S0140-6736(24)00876-6","volume":"403","author":"IN Okeke","year":"2024","unstructured":"Okeke IN, de Kraker MEA, Van Boeckel TP, Kumar CK, Schmitt H, Gales AC, Bertagnolio S, Sharland M, Laxminarayan R (2024) The scope of the antimicrobial resistance challenge. Lancet (London England) 403(10442):2426\u20132438","journal-title":"Lancet (London England)"},{"key":"5232_CR2","unstructured":"WHO: WHO Bacterial Priority Pathogens List (2024): bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. In. Geneva: World Health Organization; 2024"},{"issue":"12","key":"5232_CR3","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01220-24","volume":"62","author":"S Sabour","year":"2024","unstructured":"Sabour S, Harrington KRV, Martinson E, Bhatnagar AS, Huang JY, Duffy D, Bantle K, Lutgring JD, Karlsson M, Brown AC (2024) Characterization of carbapenem-resistant enterobacterales and Pseudomonas aeruginosa carrying multiple carbapenemase genes-Antimicrobial resistance laboratory network, 2018\u20132022. J Clin Microbiol 62(12):e0122024","journal-title":"J Clin Microbiol"},{"issue":"4","key":"5232_CR4","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00008-23","volume":"36","author":"L Ding","year":"2023","unstructured":"Ding L, Shen S, Chen J, Tian Z, Shi Q, Han R, Guo Y, Hu F (2023) Klebsiella pneumoniae carbapenemase variants: the new threat to global public health. Clin Microbiol Rev 36(4):e0000823","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"5232_CR5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jinf.2023.02.004","volume":"86","author":"R Zhang","year":"2023","unstructured":"Zhang R, Li Y, Chen J, Liu C, Sun Q, Shu L, Chen G, Wang Z, Wang S, Li R (2023) Population genomic analysis reveals the emergence of high-risk carbapenem-resistant Escherichia coli among ICU patients in China. J Infect 86(4):316\u2013328","journal-title":"J Infect"},{"issue":"3","key":"5232_CR6","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1016\/S2666-5247(22)00329-9","volume":"4","author":"J Reyes","year":"2023","unstructured":"Reyes J, Komarow L, Chen L, Ge L, Hanson BM, Cober E, Herc E, Alenazi T, Kaye KS, Garcia-Diaz J et al (2023) Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study. Lancet Microbe 4(3):e159\u2013e170","journal-title":"Lancet Microbe"},{"key":"5232_CR7","doi-asserted-by":"crossref","unstructured":"Mustafa MH, Khandekar S, Tunney MM, Elborn JS, Kahl BC, Denis O, Pl\u00e9siat P, Traore H, Tulkens PM, Vanderbist F et al (2017) Acquired resistance to macrolides in Pseudomonas aeruginosa from cystic fibrosis patients. Eur Respir J 49(5)","DOI":"10.1183\/13993003.01847-2016"},{"key":"5232_CR8","doi-asserted-by":"crossref","unstructured":"Le Terrier C, Raro OHF, Saad AM, Nordmann P, Poirel L (2024) In-vitro activity of newly-developed \u03b2-lactamase inhibitors avibactam, relebactam and vaborbactam in combination with anti-pseudomonal \u03b2-lactam antibiotics against AmpC-overproducing clinical Pseudomonas aeruginosa isolates. Eur J Clin Microbiol Infect Diseases: Official Publication Eur Soc Clin Microbiol","DOI":"10.1007\/s10096-024-04965-x"},{"key":"5232_CR9","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00115-20","author":"D Yahav","year":"2020","unstructured":"Yahav D, Giske CG, Gr\u0101matniece A, Abodakpi H, Tam VH, Leibovici L (2020) New \u03b2-lactam-\u03b2-lactamase inhibitor combinations. Clin Microbiol Rev. https:\/\/doi.org\/10.1128\/CMR.00115-20","journal-title":"Clin Microbiol Rev"},{"key":"5232_CR10","doi-asserted-by":"publisher","first-page":"100973","DOI":"10.1016\/j.drup.2023.100973","volume":"69","author":"X Li","year":"2023","unstructured":"Li X, Zhang X, Cai H, Zhu Y, Ji J, Qu T, Tu Y, Zhou H, Yu Y (2023) Overexpression of bla(GES-1) due to a strong promoter in the class 1 integron contributes to decreased ceftazidime-avibactam susceptibility in carbapenem-resistant Pseudomonas aeruginosa ST235. Drug Resist Updat 69:100973","journal-title":"Drug Resist Updat"},{"issue":"1","key":"5232_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jinf.2022.10.003","volume":"86","author":"JA Lee","year":"2023","unstructured":"Lee JA, Du SH, Lee TF, Huang YS, Liao CH, Huang YT, Hsueh PR (2023) Rapid emergence of ceftazidime-avibactam resistance among carbapenem-resistant enterobacterales in a tertiary-care hospital in Taiwan. J Infect 86(1):66\u2013117","journal-title":"J Infect"},{"key":"5232_CR12","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00642-17","author":"G Haidar","year":"2017","unstructured":"Haidar G, Clancy CJ, Chen L, Samanta P, Shields RK, Kreiswirth BN, Nguyen MH (2017) Identifying spectra of activity and therapeutic niches for Ceftazidime-Avibactam and Imipenem-Relebactam against Carbapenem-Resistant Enterobacteriaceae. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.00642-17","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"5232_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2024.107414","volume":"65","author":"Z Tan","year":"2024","unstructured":"Tan Z, Lin Y, Fan J, Jia Y, Zheng S, Wang X, Gao C, Zhang Z, Li B, Chu H (2024) FL058, a novel \u03b2-lactamase inhibitor, increases the anti-Mycobacterium abscessus activity of imipenem. Int J Antimicrob Agents 65(2):107414","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"5232_CR14","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s10096-025-05080-1","volume":"44","author":"M Boattini","year":"2025","unstructured":"Boattini M, Gaibani P, Comini S, Costa C, Cavallo R, Broccolo F, Bianco G (2025) In vitro activity and resistance mechanisms of novel antimicrobial agents against metallo-\u03b2-lactamase producers. Eur J Clin Microbiol Infect Diseases: Official Publication Eur Soc Clin Microbiol 44(5):1041\u20131068","journal-title":"Eur J Clin Microbiol Infect Diseases: Official Publication Eur Soc Clin Microbiol"},{"issue":"1","key":"5232_CR15","doi-asserted-by":"publisher","first-page":"e0133023","DOI":"10.1128\/aac.01330-23","volume":"68","author":"Z Huang","year":"2024","unstructured":"Huang Z, Yang X, Jin Y, Yu J, Cao G, Wang J, Hu Y, Dai J, Wu J, Wei Q et al (2024) First-in-human study to evaluate the safety, tolerability, and population pharmacokinetic\/pharmacodynamic target attainment analysis of FL058 alone and in combination with meropenem in healthy subjects. Antimicrob Agents Chemother 68(1):e0133023","journal-title":"Antimicrob Agents Chemother"},{"key":"5232_CR16","doi-asserted-by":"publisher","first-page":"1282480","DOI":"10.3389\/fphar.2024.1282480","volume":"15","author":"Z Huang","year":"2024","unstructured":"Huang Z, Bian X, Li Y, Hu J, Guo B, Yang X, Jin Y, Zheng S, Wang X, Gao C et al (2024) In vitro pharmacokinetics\/pharmacodynamics of FL058 (a novel beta-lactamase inhibitor) combined with meropenem against carbapenemase-producing enterobacterales. Front Pharmacol 15:1282480","journal-title":"Front Pharmacol"},{"key":"5232_CR17","doi-asserted-by":"publisher","first-page":"1516979","DOI":"10.3389\/fmicb.2024.1516979","volume":"15","author":"Z Huang","year":"2024","unstructured":"Huang Z, Li W, Zhang R, Li Y, Li X, Bian X, Zheng S, Wang X, Zhang N, Gao C et al (2024) Pharmacokinetic\/pharma-codynamic study of pralurbactam (FL058) combined with meropenem in a neutropenic murine thigh infection model. Front Microbiol 15:1516979","journal-title":"Front Microbiol"},{"issue":"1","key":"5232_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2010.12.002","volume":"70","author":"L Poirel","year":"2011","unstructured":"Poirel L, Walsh TR, Cuvillier V, Nordmann P (2011) Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 70(1):119\u2013123","journal-title":"Diagn Microbiol Infect Dis"},{"key":"5232_CR19","volume-title":"CLSI, M07","author":"CLSI","year":"2024","unstructured":"CLSI (2024) Methods for Dilution antimicrobial susceptibility tests for bacteria that grow aerobically. CLSI, M07, 12th edn. Clinical and Laboratory Standards Institute, Wayne, PA","edition":"12"},{"key":"5232_CR20","volume-title":"CLSI supplement M100","author":"CLSI","year":"2024","unstructured":"CLSI (2024) Performance standards for antimicrobial susceptibility testing. CLSI supplement M100, 34th edn. Clinical and Laboratory Standards Institute, Wayne, PA","edition":"34"},{"key":"5232_CR21","volume-title":"Breakpoint tables for interpretation of mics and zone diameters. Version 15.0. In","author":"EUCAST","year":"2025","unstructured":"EUCAST (2025) Breakpoint tables for interpretation of mics and zone diameters. Version 15.0. In. European Committee on Antimicrobial Susceptibility Testing, Sweden"},{"key":"5232_CR22","unstructured":"Lorian V (2005) Antibiotics in laboratory medicine, 5th edn. Lippincott Williams $ Wilkins"},{"issue":"1","key":"5232_CR23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.foodchem.2011.11.015","volume":"132","author":"Y Wang","year":"2012","unstructured":"Wang Y, Zhang Q, Zhang CL, Li P (2012) Characterisation and cooperative antimicrobial properties of chitosan\/nano-ZnO composite nanofibrous membranes. Food Chem 132(1):419\u2013427","journal-title":"Food Chem"},{"issue":"3","key":"5232_CR24","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01898-24","volume":"13","author":"JM Maher","year":"2025","unstructured":"Maher JM, Huband MD, Lindley JM, Rhomberg PR, Aronin SI, Puttagunta S, Castanheira M (2025) Characterization of Sulopenem antimicrobial activity using in vitro time-kill kinetics, synergy, post-antibiotic effect, and sub-inhibitory MIC effect methods against Escherichia coli and Klebsiella pneumoniae isolates. Microbiol Spectr 13(3):e0189824","journal-title":"Microbiol Spectr"},{"key":"5232_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2023.103857","volume":"44","author":"H Ji","year":"2023","unstructured":"Ji H, Dong T, Liang G, Xu H, Wang C, Liu T, Hong G (2023) Evaluation of antibacterial effect of a cationic porphyrin derivative on Pseudomonas aeruginosa in photodynamic therapy. Photodiagnosis Photodyn Ther 44:103857","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"5232_CR26","doi-asserted-by":"publisher","first-page":"823684","DOI":"10.3389\/fcimb.2022.823684","volume":"12","author":"SS Jean","year":"2022","unstructured":"Jean SS, Harnod D, Hsueh PR (2022) Global threat of carbapenem-resistant gram-negative bacteria. Front Cell Infect Microbiol 12:823684","journal-title":"Front Cell Infect Microbiol"},{"issue":"10459","key":"5232_CR27","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"GAR Collaborators","year":"2024","unstructured":"Collaborators GAR (2024) Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet (London England) 404(10459):1199\u20131226","journal-title":"Lancet (London England)"},{"issue":"3","key":"5232_CR28","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S1473-3099(21)00399-6","volume":"22","author":"M Wang","year":"2022","unstructured":"Wang M, Earley M, Chen L, Hanson BM, Yu Y, Liu Z, Salcedo S, Cober E, Li L, Kanj SS et al (2022) Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study. Lancet Infect Dis 22(3):401\u2013412","journal-title":"Lancet Infect Dis"},{"key":"5232_CR29","doi-asserted-by":"crossref","unstructured":"Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA (2024) Infectious diseases society of America 2024 guidance on the treatment of Antimicrobial-Resistant Gram-Negative infections. Clin Infect Dis","DOI":"10.1093\/cid\/ciae403"},{"issue":"1","key":"5232_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41564-024-01883-8","volume":"10","author":"MM Tu","year":"2025","unstructured":"Tu MM, Carfrae LA, Rachwalski K, French S, Catacutan D, Gordzevich R, MacNair CR, Speagle ME, Werah F, Stokes JM et al (2025) Exploiting the fitness cost of metallo-\u03b2-lactamase expression can overcome antibiotic resistance in bacterial pathogens. Nat Microbiol 10(1):53\u201365","journal-title":"Nat Microbiol"},{"issue":"4","key":"5232_CR31","doi-asserted-by":"publisher","first-page":"107113","DOI":"10.1016\/j.ijantimicag.2024.107113","volume":"63","author":"HS Sader","year":"2024","unstructured":"Sader HS, Carvalhaes CG, Kimbrough JH, Mendes RE, Castanheira M (2024) Activity of aztreonam-avibactam against enterobacterales resistant to recently approved beta-lactamase inhibitor combinations collected in Europe, Latin America, and the Asia-Pacific region (2020\u20132022). Int J Antimicrob Agents 63(4):107113","journal-title":"Int J Antimicrob Agents"},{"key":"5232_CR32","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00128-19","author":"B Moya","year":"2019","unstructured":"Moya B, Barcelo IM, Cabot G, Torrens G, Palwe S, Joshi P, Umarkar K, Takalkar S, Periasamy H, Bhagwat S et al (2019) In vitro and in vivo activities of \u03b2-lactams in combination with the novel \u03b2-lactam enhancers zidebactam and WCK 5153 against multidrug-resistant metallo-\u03b2-lactamase-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.00128-19","journal-title":"Antimicrob Agents Chemother"},{"key":"5232_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-017-0183-2","volume":"6","author":"D Paul","year":"2017","unstructured":"Paul D, Bhattacharjee A, Bhattacharjee D, Dhar D, Maurya AP, Chakravarty A (2017) Transcriptional analysis of bla(NDM-1) and copy number alteration under carbapenem stress. Antimicrob Resist Infect Control 6:26","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"5232_CR34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12941-023-00598-8","volume":"22","author":"Q Zhao","year":"2023","unstructured":"Zhao Q, Sha L, Wu Z, Meng L, Yang F, Wu L, Yu C, Zhang H, Yu J, Jin Z (2023) Evolution of carbapenem resistance in Klebsiella pneumoniae and Escherichia coli carrying bla(NDM-1) gene: imipenem exposure results in sustained resistance memory of strains in vitro. Ann Clin Microbiol Antimicrob 22(1):46","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"4","key":"5232_CR35","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1128\/CMR.00040-09","volume":"22","author":"PD Lister","year":"2009","unstructured":"Lister PD, Wolter DJ, Hanson ND (2009) Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 22(4):582\u2013610","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"5232_CR36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijantimicag.2014.03.003","volume":"44","author":"M Rahman","year":"2014","unstructured":"Rahman M, Shukla SK, Prasad KN, Ovejero CM, Pati BK, Tripathi A, Singh A, Srivastava AK, Gonzalez-Zorn B (2014) Prevalence and molecular characterisation of new Delhi metallo-\u03b2-lactamases NDM-1, NDM-5, NDM-6 and NDM-7 in multidrug-resistant Enterobacteriaceae from India. Int J Antimicrob Agents 44(1):30\u201337","journal-title":"Int J Antimicrob Agents"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05232-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05232-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05232-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T12:36:01Z","timestamp":1763210161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05232-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["5232"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05232-3","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"13 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}